
GC61071
MK-0608
Also known as (2R,3R,4R,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyloxolane-3,4-diol
MK-0608 is a potent and orally bioavailable inhibitor of HCV replication in vitro with an EC50 of 0·3 μM (EC90=1·3 μM) in the subgenomic-replicon assay
ChemicalCAS443642-29-3MW280.28FormulaC12H16N4O4
- CAS number
- 443642-29-3
- Molecular weight
- 280.28
- Formula
- C12H16N4O4
- Solubility
- DMSO: 125 mg/mL (445·98 mM)
- InChIKey
- IRZRJANZDIOOIF-GAJNKVMBSA-N
- Catalogue number
- GC61071
- Brand
- GLPBIO
Computed properties PubChem CID 3011893 · XLogP -1.2 · TPSA 127 Ų · H-bond donors 4
- XLogP
- -1.2
- TPSA
- 127 Ų
- H-bond donors
- 4
- H-bond acceptors
- 7
- Rotatable bonds
- 2
- Heavy atoms
- 20
SMILES C[C@]1([C@@H]([C@H](O[C@H]1N2C=CC3=C(N=CN=C32)N)CO)O)O
Computed descriptors from PubChem (CID 3011893), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il